BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1007 related articles for article (PubMed ID: 12808465)

  • 1. The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA.
    Zhang H; Yang B; Pomerantz RJ; Zhang C; Arunachalam SC; Gao L
    Nature; 2003 Jul; 424(6944):94-8. PubMed ID: 12808465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts.
    Mangeat B; Turelli P; Caron G; Friedli M; Perrin L; Trono D
    Nature; 2003 Jul; 424(6944):99-103. PubMed ID: 12808466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Good to CU.
    Gu Y; Sundquist WI
    Nature; 2003 Jul; 424(6944):21-2. PubMed ID: 12840737
    [No Abstract]   [Full Text] [Related]  

  • 4. A single amino acid substitution in human APOBEC3G antiretroviral enzyme confers resistance to HIV-1 virion infectivity factor-induced depletion.
    Xu H; Svarovskaia ES; Barr R; Zhang Y; Khan MA; Strebel K; Pathak VK
    Proc Natl Acad Sci U S A; 2004 Apr; 101(15):5652-7. PubMed ID: 15054139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The innate antiretroviral defense of human cells, based on the DNA editing].
    Pupecka M; Pacak A
    Postepy Biochem; 2006; 52(3):247-52. PubMed ID: 17201059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein.
    Sheehy AM; Gaddis NC; Choi JD; Malim MH
    Nature; 2002 Aug; 418(6898):646-50. PubMed ID: 12167863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Death by deamination: a novel host restriction system for HIV-1.
    Goff SP
    Cell; 2003 Aug; 114(3):281-3. PubMed ID: 12914693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of primate lentiviral Vif and proteasome inhibitors on human immunodeficiency virus type 1 virion packaging of APOBEC3G.
    Liu B; Yu X; Luo K; Yu Y; Yu XF
    J Virol; 2004 Feb; 78(4):2072-81. PubMed ID: 14747572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New insights into the role of Vif in HIV-1 replication.
    Schröfelbauer B; Yu Q; Landau NR
    AIDS Rev; 2004; 6(1):34-9. PubMed ID: 15168739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. APOBEC3G targets human T-cell leukemia virus type 1.
    Sasada A; Takaori-Kondo A; Shirakawa K; Kobayashi M; Abudu A; Hishizawa M; Imada K; Tanaka Y; Uchiyama T
    Retrovirology; 2005 May; 2():32. PubMed ID: 15943885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Death and the retrovirus.
    Vartanian JP; Sommer P; Wain-Hobson S
    Trends Mol Med; 2003 Oct; 9(10):409-13. PubMed ID: 14557052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The human immunodeficiency virus type 1 Vif protein reduces intracellular expression and inhibits packaging of APOBEC3G (CEM15), a cellular inhibitor of virus infectivity.
    Kao S; Khan MA; Miyagi E; Plishka R; Buckler-White A; Strebel K
    J Virol; 2003 Nov; 77(21):11398-407. PubMed ID: 14557625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-1 Vif blocks the antiviral activity of APOBEC3G by impairing both its translation and intracellular stability.
    Stopak K; de Noronha C; Yonemoto W; Greene WC
    Mol Cell; 2003 Sep; 12(3):591-601. PubMed ID: 14527406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypermutation of HIV-1 DNA in the absence of the Vif protein.
    Lecossier D; Bouchonnet F; Clavel F; Hance AJ
    Science; 2003 May; 300(5622):1112. PubMed ID: 12750511
    [No Abstract]   [Full Text] [Related]  

  • 15. Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex.
    Yu X; Yu Y; Liu B; Luo K; Kong W; Mao P; Yu XF
    Science; 2003 Nov; 302(5647):1056-60. PubMed ID: 14564014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virology. Weapons of mutational destruction.
    KewalRamani VN; Coffin JM
    Science; 2003 Aug; 301(5635):923-5. PubMed ID: 12920286
    [No Abstract]   [Full Text] [Related]  

  • 17. Recent insights into HIV-1 Vif.
    Navarro F; Landau NR
    Curr Opin Immunol; 2004 Aug; 16(4):477-82. PubMed ID: 15245742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population level analysis of human immunodeficiency virus type 1 hypermutation and its relationship with APOBEC3G and vif genetic variation.
    Pace C; Keller J; Nolan D; James I; Gaudieri S; Moore C; Mallal S
    J Virol; 2006 Sep; 80(18):9259-69. PubMed ID: 16940537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vif overcomes the innate antiviral activity of APOBEC3G by promoting its degradation in the ubiquitin-proteasome pathway.
    Mehle A; Strack B; Ancuta P; Zhang C; McPike M; Gabuzda D
    J Biol Chem; 2004 Feb; 279(9):7792-8. PubMed ID: 14672928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV-1 Vif can directly inhibit apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like 3G-mediated cytidine deamination by using a single amino acid interaction and without protein degradation.
    Santa-Marta M; da Silva FA; Fonseca AM; Goncalves J
    J Biol Chem; 2005 Mar; 280(10):8765-75. PubMed ID: 15611076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 51.